Avanos Medical (AVNS) Divestments (2018 - 2024)

Avanos Medical (AVNS) reported Divestments of -$2.1 million for Q4 2024, down 102.36% on a YoY basis from $89.0 million in Q1 2024, and down 200.0% sequentially from $2.1 million in Q1 2024.

Avanos Medical (AVNS) Divestments (2018 - 2024) Analysis & Trends

Avanos Medical (AVNS) has 3 years of Divestments data on file, last reported at -$2.1 million in Q4 2024.

  • For the quarter ending Q4 2024, Divestments fell 102.36% year-over-year to -$2.1 million; the trailing twelve-month figure through Sep 2025 stood at -$2.1 million (down 102.31% YoY), and the FY2023 full-year result was $89.0 million, changed N/A from the prior year.
  • Divestments declined to -$2.1 million in Q4 2024, from $2.1 million in the prior quarter.
  • In the past five years, Divestments ranged from a high of $89.0 million in Q4 2023 to a low of -$2.1 million in Q4 2024.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Divestments (Qtr)
1 Abbott Laboratories 182.32 Bn 175.02 Bn 6.27 Bn -
2 Stryker 128.75 Bn 125.88 Bn 3.81 Bn -
3 Medtronic 107.83 Bn 98.61 Bn 6.41 Bn -
4 Boston Scientific 67.61 Bn 66.15 Bn 3.61 Bn -
5 Edwards Lifesciences 48.13 Bn 44.45 Bn 1.29 Bn -
6 Dexcom 28.26 Bn 27.14 Bn 750.30 Mn -
7 GE HealthCare Technologies 27.78 Bn 25.50 Bn 1.98 Bn -
8 Smith & Nephew 26.99 Bn 26.41 Bn - -
9 Koninklijke Philips 23.92 Bn 20.80 Bn 2.07 Bn 9.37 Mn
10 Avanos Medical 1.16 Bn 1.10 Bn 94.20 Mn -

Historic Data

Download Data
DateValue
Dec 31, 2024 -2.10 Mn
Mar 31, 2024 2.10 Mn
Dec 31, 2023 89.00 Mn
Sep 30, 2018 19.80 Mn